This was on the PC Infolink today and I found it valuable:
"
a 42-minute-long presentation by Dr. Laurence Klotz on the present and future role of active surveillance in the management of low-risk prostate cancer (and intermediate-risk prostate cancer in older men with a limited life expectancy). Dr. Klotz goes into great detail about everything from the extreme unlikelihood for metastasis of any prostate cancer with a Gleason score of 6 or less to the evolving role of MRI scanning and MRI/TRUS-fusion biopsies in the monitoring of patients on active surveillance. For those readers who are seeking a detailed understanding of the application of active surveillance today, this video is well worth 42 minutes of your time, and one could project it, with the audio at a support group meeting if the relevant equiment was available."
www.urotoday.com/208-active-surveillance